Capital Research Global Investors Abbott Laboratories Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Research Global Investors holds 83,984,731 shares of ABT stock, worth $8.58 Billion. This represents 2.23% of its overall portfolio holdings.

Number of Shares

83,984,731

Previous 86,588,614 3.01%

Holding current value

$8.58 Billion

Previous $9.53 Billion 0.16%

% of portfolio

2.23%

Previous 2.4%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $285 Million - $315 Million	-2,603,883 Reduced 3.01%	83,984,731 $9.55 Billion
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $679 Million - $831 Million	7,527,778 Added 9.52%	86,588,614 $9.53 Billion
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $175 Million - $210 Million	1,835,578 Added 2.38%	79,060,836 $7.66 Billion
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $82.7 Million - $92.1 Million	820,369 Added 1.07%	77,225,258 $8.42 Billion
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $36.9 Million - $43.4 Million	-380,473 Reduced 0.5%	76,404,889 $7.74 Billion

Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $192 Million - $225 Million	-2,021,452 Reduced 2.57%	76,785,362 $8.43 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $125 Million - $145 Million	-1,290,514 Reduced 1.61%	78,806,814 $7.63 Billion
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $59.2 Million - $71.6 Million	-580,262 Reduced 0.72%	80,097,328 $8.7 Billion
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $393 Million - $479 Million	-3,447,439 Reduced 4.1%	80,677,590 $9.55 Billion
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $37.9 Million - $46.4 Million	-327,768 Reduced 0.39%	84,125,029 $11.8 Billion
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $160 Million - $177 Million	-1,368,008 Reduced 1.59%	84,452,797 $9.98 Billion
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $3.12 Million - $3.68 Million	29,539 Added 0.03%	85,820,805 $9.95 Billion
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $65.6 Million - $77.3 Million	-602,933 Reduced 0.7%	85,791,266 $10.3 Billion
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $107 Million - $117 Million	-1,019,461 Reduced 1.17%	86,394,199 $9.46 Billion
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $373,341 - $453,395	-4,074 Reduced -0.0%	87,413,660 $9.51 Billion
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $647 Million - $828 Million	-8,450,164 Reduced 8.81%	87,417,734 $7.99 Billion
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $1.12 Billion - $1.64 Billion	-17,821,395 Reduced 15.68%	95,867,898 $7.56 Billion
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $48.4 Million - $53.9 Million	616,255 Added 0.55%	113,689,293 $9.88 Billion
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $304 Million - $330 Million	-3,716,315 Reduced 3.18%	113,073,038 $9.46 Billion
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $88.8 Million - $104 Million	1,217,776 Added 1.05%	116,789,353 $9.82 Billion
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $421 Million - $509 Million	-6,356,769 Reduced 5.21%	115,571,577 $9.24 Billion
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $213 Million - $241 Million	-3,241,452 Reduced 2.59%	121,928,346 $8.82 Billion
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $361 Million - $435 Million	-5,929,990 Reduced 4.52%	125,169,798 $9.18 Billion
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $1.04 Billion - $1.14 Billion	18,000,566 Added 15.92%	131,099,788 $8 Billion
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $1.57 Billion - $1.78 Billion	27,958,563 Added 32.84%	113,099,222 $6.78 Billion
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $928 Million - $993 Million	17,279,533 Added 25.46%	85,140,659 $4.86 Billion
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $3.26 Billion - $3.64 Billion	67,861,126	67,861,126 $3.62 Billion

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Abbott Laboratories Transaction History